Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases

NCT00623766 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Ipilimumab
DRUG: Corticosteroid: Betamethasone
DRUG: Corticosteroid: Dexamethasone
DRUG: Corticosteroid: Fludrocortisone
DRUG: Corticosteroid: Hydrocortisone
DRUG: Corticosteroid: Meprednisone
DRUG: Corticosteroid: Methylprednisolone
DRUG: Corticosteroid: Prednisolone
DRUG: Corticosteroid: Prednisone
DRUG: Corticosteroid: Triamcinolone

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]